Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Material Command is a synthetic biology company focused on the design and production of advanced materials using biological systems. Founded by veterans of the synthetic biology industry, the company leverages a platform approach to program cells for the manufacture of high-performance materials that are difficult to produce via traditional chemistry. Their technology aims to bridge the gap between biological design and industrial-scale material production. The company is currently in an early stage of development, focusing on scaling its biological manufacturing capabilities. Material Command is headquartered in Cambridge, Massachusetts, and is backed by prominent venture capital firms specializing in deep tech and biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Material Command.